A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2001
11/15/2001	WO2001040255A3 14,15-beta-methylene substituted androgens
11/15/2001	WO2001032878A3 A novel polypeptide hormone phosphatonin
11/15/2001	WO2001016136B1 Tricyclic inhibitors of poly(adp-ribose) polymerases
11/15/2001	US20010041730 (1S,2S)-2-(2-(N-((3-benzoimidazol-2-yl)propyl)-N-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041703 Which are growth hormone secretogogues and increase the level of endogenous growth hormone; treating osteoporosis, congestive heart failure, frailty associated with aging, obesity; accelerating bone fracture repair
11/15/2001	US20010041695 Orally administering to a post-menopausal woman a fat soluble vitamin and a fat soluble vitamin absorption increasing effective amount of L-carnitine or salts
11/15/2001	DE10113328A1 New herbal composition for treating gynecological and other related disorders comprises solvent extracted herbal extract and a plant coagulate
11/15/2001	CA2408818A1 Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with ns398 or pdtc
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	CA2408559A1 Polynucleotides encoding for polymorphic isoforms of the pthrp protein, the encoded proteins and their therapeutic applications thereof
11/15/2001	CA2408290A1 New polycyclic indanylimidazoles with alpha2 adrenergic activity
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153039A2 Use of blocking anti-tsh-receptor-antibodies in the therapy of hyperthyreoses and monoclonal antibodies for a use of this type
11/14/2001	EP1153034A1 Growth hormone secretagogues
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP1152749A2 Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
11/14/2001	CN1322200A Enantioselective synthesis
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316432 Antigestagenically active steroids with a flourinated 17 α-alkyl chain
11/13/2001	US6316431 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents
11/13/2001	US6316410 Amino acid sequences of peptide hormones
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083475A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	WO2001083427A1 PPARη MODULATORS
11/08/2001	WO2001083425A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/08/2001	WO2001082981A1 A medicinal aerosol formulation
11/08/2001	WO2001082910A2 Combination of progesterone and mifepristone for cancer therapy
11/08/2001	WO2001082900A1 Non-invasive gene targeting to the brain
11/08/2001	WO2001082897A2 Liposome drug delivery
11/08/2001	WO2001037780A8 Urotensin-ii analogs
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2000076556A9 High dose radionuclide complexes for bone marrow suppression
11/08/2001	WO2000074666A3 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
11/08/2001	US20010039294 11-beta-reductase inhibitor such as carbenoxolone to control 11-keto steroid conversion to 11-beta-hydroxysteroid; antidiabetic agents
11/08/2001	US20010039289 Antagonists; especially sodium salts
11/08/2001	US20010039285 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
11/08/2001	US20010039280 Optically active 3-[(2-Piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT 1D receptor selective antagonists
11/08/2001	US20010039269 Treatment of prostate disorders such as prostatic cancer
11/08/2001	CA2408011A1 Splice-region antisense composition and method
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407587A1 Ppar.gamma. modulators
11/08/2001	CA2407418A1 Novel heterocyclic compounds with anti-inflammatory activity
11/08/2001	CA2407134A1 Cancer therapy
11/08/2001	CA2405611A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives
11/07/2001	EP1151998A1 Estrogen agonists/antagonists
11/07/2001	EP1151746A1 Microcapsules for sustained release of drugs
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1150977A1 Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
11/07/2001	EP1150698A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction
11/07/2001	EP1150683A1 Utilization of dienogest in high doses
11/07/2001	EP1150662A1 Laminates containing an active substance for transdermal systems
11/07/2001	EP1150661A2 Topical sprays comprising a film forming composition
11/07/2001	EP1150658A2 Method for controlling liposome size
11/07/2001	EP0896819A4 Antiglucocorticoid drug
11/07/2001	EP0882051B1 Thiophenopyrimidines
11/07/2001	EP0825865B1 Transdermal therapeutic system for administering testosterone
11/07/2001	EP0600028B1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones
11/07/2001	CN1321086A Mucosal originated drug delivery system and animal applications
11/07/2001	CN1320426A Compound for treatment of female sexual dysfuction
11/06/2001	US6313156 Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
11/06/2001	US6313140 Method of treatment using certain growth-hormone secret agogues
11/06/2001	US6313115 Alleviate impairment of memory, or other cognitive functions caused by hypoglutamatergic condition or by deficiency in number or strength of excitatory synapses or in number of ampa receptors
11/06/2001	US6313108 Treating androgen insufficiency
11/06/2001	US6313107 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI
11/06/2001	US6312722 Pharmaceutical combined preparation, kit and method for hormonal contraception
11/01/2001	WO2001081590A2 Protein phosphatases
11/01/2001	WO2001081585A2 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	WO2001081562A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	WO2001081415A2 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/01/2001	WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001	WO2001081337A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001081304A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001	WO2001028356A3 Food supplement for increasing lean mass and strength
11/01/2001	WO2001010847A3 Novel integrin receptor antagonists
11/01/2001	US20010036956 Estrogen receptor modulators
11/01/2001	US20010036936 Compositions and methods for treating osteoporosis
11/01/2001	US20010036925 Genetic engineering
11/01/2001	CA2407663A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407662A1 Inhibitors of dipeptidyl peptidase iv
11/01/2001	CA2407493A1 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
11/01/2001	CA2406855A1 Novel insulin/igf/relaxin family polypeptides and dnas thereof
11/01/2001	CA2406639A1 A thymus expressed human cytochrome p450 (p450tec)
11/01/2001	CA2406264A1 Protein phosphatases
10/2001
10/31/2001	EP1149843A1 Substituted phenethylamine derivatives
10/31/2001	EP1149842A2 Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
10/31/2001	EP1149097A2 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
10/31/2001	EP1149083A1 Morpholinobenzamide salts
10/31/2001	EP1148876A1 Calcilytic compounds
10/31/2001	EP1148871A1 Core tablet for controlled release of gliclazide after oral administration
10/30/2001	US6310226 Vitamin D analogues
10/30/2001	US6309671 Stable glassy state powder formulations
10/30/2001	US6309663 Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 290